4//SEC Filing
Doyle Anthony 4
Accession 0001127602-24-029573
CIK 0000882796other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:06 PM ET
Size
4.7 KB
Accession
0001127602-24-029573
Insider Transaction Report
Form 4
Doyle Anthony
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-12-14$7.53/sh−7,890$59,412→ 259,628 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the Reporting Person.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001808688
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:06 PM ET
- Size
- 4.7 KB